Neogen (NEOG) Expected to Announce Earnings on Tuesday

Neogen (NASDAQ:NEOG - Get Free Report) is anticipated to issue its Q4 2025 quarterly earnings data before the market opens on Tuesday, July 29th. Analysts expect the company to announce earnings of $0.09 per share and revenue of $222.52 million for the quarter.

Neogen Stock Up 0.3%

Shares of NEOG stock traded up $0.02 during trading hours on Thursday, reaching $5.08. The company had a trading volume of 2,477,924 shares, compared to its average volume of 5,271,453. The company has a market capitalization of $1.10 billion, a P/E ratio of -2.27 and a beta of 1.77. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.45 and a current ratio of 3.91. Neogen has a twelve month low of $3.87 and a twelve month high of $18.58. The stock's fifty day simple moving average is $5.46 and its 200 day simple moving average is $7.67.

Analyst Ratings Changes

Several brokerages have issued reports on NEOG. Piper Sandler lowered their price objective on shares of Neogen from $6.40 to $5.00 and set a "neutral" rating for the company in a research report on Tuesday, April 22nd. Guggenheim decreased their target price on shares of Neogen from $13.00 to $10.00 and set a "buy" rating for the company in a research note on Monday, June 30th.

Insider Buying and Selling at Neogen

In other Neogen news, Director Aashima Gupta bought 16,000 shares of the company's stock in a transaction dated Monday, May 12th. The shares were acquired at an average cost of $6.25 per share, with a total value of $100,000.00. Following the completion of the transaction, the director owned 21,917 shares in the company, valued at $136,981.25. The trade was a 270.41% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.13% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. United Services Automobile Association acquired a new position in shares of Neogen in the 1st quarter valued at approximately $112,000. Jones Financial Companies Lllp raised its holdings in Neogen by 5,687.3% in the first quarter. Jones Financial Companies Lllp now owns 33,393 shares of the company's stock valued at $290,000 after acquiring an additional 32,816 shares in the last quarter. AQR Capital Management LLC boosted its stake in Neogen by 217.0% during the 1st quarter. AQR Capital Management LLC now owns 52,410 shares of the company's stock valued at $443,000 after acquiring an additional 35,878 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Neogen by 4.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 129,813 shares of the company's stock worth $1,125,000 after acquiring an additional 5,638 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in Neogen by 14.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,678,493 shares of the company's stock worth $14,553,000 after acquiring an additional 209,990 shares in the last quarter. Hedge funds and other institutional investors own 96.73% of the company's stock.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.